MarketPeel
Insider Trading Intelligence
SS

Spiro Kevin Sakiris

INBS
CHIEF FINANCIAL OFFICER · INTELLIGENT BIO SOLUTIONS INC. · CIK 0001830957
FILING MIX · LIFETIME91%/9%
BUYS
10
SELLS
1
TOTAL VALUE
$20.0K
COMPANIES
1
ACTIVE SINCE
Dec 2022
HOLDINGS NOW
12,631
AVG SELL PX
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Spiro Kevin Sakiris, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+0.00%-12.51%+1.93%-14.44%-5.25%
14d5+0.00%-29.43%+0.64%-30.07%-39.92%
30d5+0.00%-29.23%+3.01%-32.24%-47.68%
60d5+40.00%+0.18%+6.46%-6.28%-33.91%
90d5+0.00%-33.08%+8.40%-41.48%-36.80%
180d5+0.00%-33.07%+20.58%-53.66%-46.95%
1y5+0.00%-78.37%+31.83%-110.20%-103.51%
2y5+0.00%-85.92%+60.30%-146.22%-138.58%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
INBS · 12,631 shares · as of Mar 18, 2026
029,35758,71488,070117,4272023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 10 buys / 1 sellsCOVERAGE · 14 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
INBS
INTELLIGENT BIO SOLUTIONS INC.
PURCHASEGRANT
Stock grant
21,35033,981Mar 18, 2026Mar 19, 2026View →
INBS
INTELLIGENT BIO SOLUTIONS INC.
PURCHASEGRANT
Stock grant
9,15012,631Mar 18, 2026Mar 19, 2026View →
INBS
INTELLIGENT BIO SOLUTIONS INC.
PURCHASEGRANT
Stock grant
34,50034,815Sep 25, 2024Mar 31, 2025View →
INBS
INTELLIGENT BIO SOLUTIONS INC.
PURCHASEGRANT
Stock grant
34,50034,815Sep 25, 2024Sep 27, 2024View →
INBS
INTELLIGENT BIO SOLUTIONS INC.
SALE
Chief Financial Officer
9,3940Mar 20, 2024Mar 21, 2024View →
INBS
INTELLIGENT BIO SOLUTIONS INC.
PURCHASE
Chief Financial Officer
9,39419,180Mar 20, 2024Mar 21, 2024View →
INBS
INTELLIGENT BIO SOLUTIONS INC.
PURCHASE
Chief Financial Officer
112,727112,727Oct 4, 2023Oct 6, 2023View →
INBS
INTELLIGENT BIO SOLUTIONS INC.
PURCHASE
Chief Financial Officer
112,727112,727Oct 4, 2023Oct 6, 2023View →
INBS
INTELLIGENT BIO SOLUTIONS INC.
PURCHASE
Chief Financial Officer
112,727117,427Oct 4, 2023Oct 6, 2023View →
INBS
INTELLIGENT BIO SOLUTIONS INC.
PURCHASE
Chief Financial Officer
15,992$0.87$13.9K15,993Dec 22, 2022Dec 23, 2022View →
INBS
INTELLIGENT BIO SOLUTIONS INC.
PURCHASE
Chief Financial Officer
47,979$0.13$6.1K47,979Dec 22, 2022Dec 23, 2022View →
Other insiders · INBS
Loading peer insiders…
About this filer
CIK 0001830957
ROLE
Chief Financial Officer
PRIMARY
INBS
COMPANIES
1
ACTIVE SINCE
Dec 2022
MARKETPEEL · /INSIDER/0001830957DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback